Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Flumazenil in benzodiazepine overdose

Howard An and Jesse Godwin
CMAJ December 06, 2016 188 (17-18) E537; DOI: https://doi.org/10.1503/cmaj.160357
Howard An
Divisions of Emergency Medicine (Godwin) and Clinical Pharmacology and Toxicology (An, Godwin), Department of Medicine, University of Toronto; Ontario Poison Centre (An, Godwin), Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: howard.an@gmail.com
Jesse Godwin
Divisions of Emergency Medicine (Godwin) and Clinical Pharmacology and Toxicology (An, Godwin), Department of Medicine, University of Toronto; Ontario Poison Centre (An, Godwin), Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
Submit a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
References
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Minimum 7 characters.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'. Minimum 12 characters.
Your organization, institution's or residential address.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

  • Zopiclone Overdose and Flumazenil Rescue
    Nevio Cimolai
    Posted on: 22 February 2017
  • Posted on: (22 February 2017)
    Page navigation anchor for Zopiclone Overdose and Flumazenil Rescue
    Zopiclone Overdose and Flumazenil Rescue
    • Nevio Cimolai, Professor

    An and Goodwin appropriately detail the use of flumazenil in select circumstances of benzodiazepine overdosing.1 As also suggested, most patients with benzodiazepine overdose recover after supportive therapy and without the need of pharmacological intervention. 'Z drugs' (including zopiclone) share GABA receptors more or less with the benzodiazepines.2 Along the same lines, zopiclone overdose has been effectively treated...

    Show More

    An and Goodwin appropriately detail the use of flumazenil in select circumstances of benzodiazepine overdosing.1 As also suggested, most patients with benzodiazepine overdose recover after supportive therapy and without the need of pharmacological intervention. 'Z drugs' (including zopiclone) share GABA receptors more or less with the benzodiazepines.2 Along the same lines, zopiclone overdose has been effectively treated with flumazenil, although again most such overuses can be treated with supportive therapy only.2,3 It would be prudent then to share the same precautions for using flumazenil in zopiclone overdosing as it would be for the benzodiazepines.

    References

    1. An H, Goodwin J. Flumazenil in benzodiazepine overdose. CMAJ 2016;December 6;188:E537.

    2. Cimolai N. Zopiclone: is it a pharmacologic agent for abuse? Can Fam Physician 2007;53:2124-9.

    3. Cimolai N. Safety with zopiclone use: contemporary issues. Curr Psychopharmacol 2017 (In press).

    Conflict of Interest:

    None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 188 (17-18)
CMAJ
Vol. 188, Issue 17-18
6 Dec 2016
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Flumazenil in benzodiazepine overdose
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Flumazenil in benzodiazepine overdose
Howard An, Jesse Godwin
CMAJ Dec 2016, 188 (17-18) E537; DOI: 10.1503/cmaj.160357

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Flumazenil in benzodiazepine overdose
Howard An, Jesse Godwin
CMAJ Dec 2016, 188 (17-18) E537; DOI: 10.1503/cmaj.160357
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Isolated benzodiazepine overdoses are rarely fatal
    • Flumazenil antagonizes benzodiazepine activity
    • Flumazenil should not be used routinely
    • Select patients may benefit from the administration of flumazenil
    • Flumazenil has a short half-life
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Zopiclone overdose and flumazenil rescue
  • PubMed
  • Google Scholar

Cited By...

  • Zopiclone overdose and flumazenil rescue
  • Google Scholar

More in this TOC Section

  • Phthiriasis palpebrarum
  • Penicillin allergy delabelling in pregnancy
  • Penicillin allergy delabelling of patients at risk of sexually transmitted infections in primary care
Show more Practice

Similar Articles

Collections

  • Topics
    • Drugs: adverse reactions
    • Drugs: central nervous system (not psychiatric)
    • Emergency medicine
    • Pharmacology & toxicology

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire